Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo. 2014

Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
Department of Veterinary Medicine and Animal Production, University of Naples "Federico II", Via Delpino no. 1, 80137 Naples, Italy. Electronic address: serena.montagnaro@unina.it.

Water buffalo (Bubalus bubalis) are susceptible to bovine herpesvirus type 1 (BoHV-1) and a species-specific herpesvirus, bubaline herpesvirus type 1 (BuHV-1). In this study, an attenuated marker BoHV-1 based vaccine against BuHV-1 challenge was evaluated to determine whether it induces protection from viral replication. One group of water buffalo calves was immunized with an attenuated BoHV-1 marker vaccine. A second group was not vaccinated and used as the control. During the post-vaccination period, we monitored the humoral immune response. The efficacy of the vaccine was tested after intranasal challenge of the calves with a BuHV-1 strain. The experiment showed that after vaccination, BuHV-1 replication was significantly reduced by approximately three titer points compared to the controls. The control animals showed high levels of viral shedding and mild signs associated with BuHV-1 infection. Therefore, our study provides evidence for the existence of cross-protection between BoHV-1 and BuHV-1 in buffalo calves.

UI MeSH Term Description Entries
D007242 Herpesvirus 1, Bovine A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE. IBR-IPV Virus,Infectious Bovine Rhinotracheitis Virus,Infectious Pustular Vulvovaginitis Virus,Bovine Herpesvirus 1,Bovine Rhinotracheitis Virus, Infectious,Herpesvirus 1 (alpha), Bovine,Pustular Vulvovaginitis Virus, Infectious,IBR IPV Virus,IBR-IPV Viruses,Virus, IBR-IPV,Viruses, IBR-IPV
D008297 Male Males
D002020 Buffaloes Ruminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus. Bubalus,Syncerus,Water Buffaloes,Buffalo,Water Buffalo,Buffalo, Water
D005260 Female Females
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D056738 Cross Protection Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus. Protection, Cross

Related Publications

Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
June 2013, Research in veterinary science,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
October 1996, Veterinary microbiology,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
March 2006, Veterinary microbiology,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
December 2016, The veterinary quarterly,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
March 2024, Microbiology resource announcements,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
July 2001, Vaccine,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
April 2006, Vaccine,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
February 2023, Microorganisms,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
April 2021, Vaccines,
Serena Montagnaro, and Claudio De Martinis, and Valentina Iovane, and Roberto Ciarcia, and Sara Damiano, and Sandra Nizza, and Luisa De Martino, and Giuseppe Iovane, and Ugo Pagnini
January 2020, Tropical animal health and production,
Copied contents to your clipboard!